N/A interviewed by Mona Sadeghpour, MD, FAAD

Are you curious about the hottest trending topics in dermatology? In this latest episode of “DiD You Know?,” Dr. Mona Sadeghpour reviews the novel use of IL-5 inhibitors as a steroid-sparing therapy for drug-induced hypersensitivity syndrome (DIHS), previously knowns as drug reaction with eosinophilia and systemic symptoms (DRESS). For more information, visit the August “What’s Hot” column of DermWorld at https://www.aad.org/dw/monthly/2025/august/whats-hot-august-2025.

Shannon Wongvibulsin, MD, PhD and Shreya Johri, PhD interviewed by William Lewis, MD

Ellen J. Kim, MD, FAAD interviewed by Steven Chen, MD, MPH, FAAD

This episode has been sponsored by Kyowa Kirin.

View episode transcript

Veena Vanchinathan, MD, FAAD interviewed by Sabrina Shearer, MD, FAAD

Trilokraj Tejasvi, MD, MBBS interviewed by Brad P. Glick, DO, MPH, FAAD

Adam Friedman, MD, FAAD interviewed by Sabrina Shearer, MD, FAAD

This episode is supported by an educational grant from Novartis.

View episode transcript

Shawn Kwatra, MD, FAAD interviewed by Sabrina Shearer, MD, FAAD

This episode is supported by an educational grant from Galderma.

View episode transcript

Kevin M. Crawford, MD, FAAD interviewed by Mona Sadeghpour, MD, FAAD

Romana Behshad, MD, FAAD interviewed by Martina Porter, MD, FAAD

interviewed by Mona Sadeghpour, MD, FAAD

Are you curious about the latest trending topics in dermatology? In the latest episode of "DiD You Know?,” Dr. Mona Sadeghpour reviews a new risk model that shows improved prognostication for cutaneous SCCs, particularly those with poor outcomes, while also delivering a personalized risk assessment. For more information, visit the May “What’s Hot” column of DermWorld at https://www.aad.org/dw/monthly/2025/may/whats-hot-may-2025.